
📅 Save the date! EORTC events are back in 2026 ⬇️ #CancerResearch #ClinicalTrials #Oncology #EORTCevents

European Organisation for #Research and #Treatment of #Cancer defines better treatments for all cancer #patients to prolong survival and improve quality of life

📅 Save the date! EORTC events are back in 2026 ⬇️ #CancerResearch #ClinicalTrials #Oncology #EORTCevents

Opening Keynote at #ENASymp2026! Prof. Tony S.K. Mok delivering the opening keynote lecture, "The Rise of Biotech in APAC", exploring the growing role of biotechnology in advancing cancer therapeutics. 📅 18 November | 13:35–14:20 📍 Plenary Room 111+112 #CancerResearch

Have you explored the poster exhibition yet? Take advantage of your lunch break at #ENASymp26 to explore new findings and meet the researchers behind the work. Head to the Exhibition Hall and check out the posters! 📍 Exhibition Hall | 12:00–13:30 #CancerResearch

#ENASymp26 kicks off today in Barcelona! Join fellow participants for an evening of networking and connections at our Networking Reception. 📍 Exhibition Hall | 17:45–19:00 #CancerResearch

📢 EORTC is proud to be part of ResPECT, a @HorizonEU project developing trustworthy AI solutions to turn patients' lived experiences into actionable insights for care, research and health policy. Learn more: eortc.org/blog/2026/11/12/eu… #HorizonEU #GenAI4EU #QualityofLife

Strong research needs strong leaders. 40 investigators from 16 countries selected for EORTC's Y-ECI 2027 programme! Thanks to Princess Laetitia and our donors for supporting future cancer research leaders. donate.eortcresearchfund.org… #ECRF

🎗️🫁 November is #LungCancerAwarenessMonth! In 2024, an estimated 2.6M people were diagnosed with lung cancer and 1.9M died worldwide. At EORTC Lung Cancer Group, we advance prevention, early detection and research. Learn more: eortc.org/research_field/lun… #EORTClung

📢 SAVE THE DATE MCCR 2027 MCCR returns on 20–24 June 2027 in the Netherlands for a week of expert-led training in clinical trial design! @myESMO @AACR 🗓️ Applications: 1 December 2026 🔗 event.eortc.org/mccr2027/ #MCCRworkshop #ClinicalTrialDesign

🚀 Pilot access is now open for EORTC PROcoach, our new e-learning course on the use of patient-reported outcome measures in clinical practice. 👉 Explore the course and share your feedback to help shape its final development: qol.eortc.org/e-learning-pla… #QualityofLife @EORTC_QLG

📢 Late rate ends 4 November! Join the international oncology research community at #ENASymp26. ⏰ Register now: event.eortc.org/ena2026/regi… @AACR @theNCI #CancerResearch #Oncology

We're hiring a Junior Clinical Operations Manager at EORTC. Help support the planning, coordination and execution of international clinical studies that advance cancer treatment. 📍Brussels, Belgium 👉 Apply here: eortc.org/job/junior-clinica… #Hiring #ClinicalResearch #EORTC

📘 How can researchers better involve patients & caregivers in #QualityofLife research? The new Guidance for Patient Involvement in the @EORTC_QLG offers practical recommendations & resources to support meaningful patient involvement. 🔗 qol.eortc.org/manual/guidanc… #CancerResearch

👏 Proud to see the @EORTC Quality of Life Group featured at the 27th Panhellenic Urology Congress. By showcasing the EORTC HRQoL measurement system & the QLQ-RCC38 module development, we continue to promote the value of PROs & #QualityofLife research in #CancerCare. @ISUReHub

🎗️ What quality of life issues matter most to people living with metastatic breast cancer? This joint study from the EORTC #QualityofLife and #BreastCancer Groups identified key patient priorities and supports development of the EORTC QLQ‑MBR module. 🔗 eortc.org/publications/

The first participating site is now active in #EORTC STARBURST-1. Led by Prof Alexandra Masson-Lecomte and involving 20 centres, this study will investigate mpMRI, NacVI-RADS, tumour DNA and molecular classifications in muscle-invasive bladder cancer. 🔗 eortc.org/blog/2026/10/28/fs…

🌍An important EORTC #QualityofLife Group publication led by @csimoes96 and colleagues, proposing a flexible and actionable approach to HRQoL assessment in people diagnosed with solid rare cancers. 👇 #CancerResearch #RareCancers #GivingVoice2Patients @Winette_vdGraaf @OlgaHusson
🔍 New @EORTC #QualityofLife Group publication. In 397 patients across 20 solid rare cancer diagnoses, the EORTC QLQ‑C30 proved relevant for assessing HRQoL, and combining it with tailored item lists may better capture what matters most to patients. 🔗 eortc.org/publications/
View quoted post ↗